Integra LifeSciences announced the acquisition of Rebound Therapeutics Sept. 9, adding the company’s minimally invasive neurosurgery system.
Four things to know:
1. The neurosurgery platform features integrated optics and illumination, enabling interfacing with OR monitors.
2. The technology expands Integra’s neurosurgical and therapeutic-focused portfolio.
3. Integra doesn’t anticipate the acquisition to have a material financial impact this year.
4. Financial terms of the deal were not disclosed.
More articles on devices:
'A dream come true': Dr. Jorge Chahla strives for success at Rush
New York hospital invests $2M in imaging system for spine, brain — 4 things to know
What Stryker's spine division stands to gain from 5 acquisitions